nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—HTR2A—Gilles de la Tourette syndrome	0.844	1	CbGaD
Epinastine—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00866	0.205	CbGeAlD
Epinastine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.0054	0.128	CbGeAlD
Epinastine—HRH2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00305	0.0297	CbGpPWpGaD
Epinastine—HTR7—Serotonin receptors—HTR2A—Gilles de la Tourette syndrome	0.00284	0.0276	CbGpPWpGaD
Epinastine—HRH2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0026	0.0254	CbGpPWpGaD
Epinastine—HRH2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00253	0.0246	CbGpPWpGaD
Epinastine—HRH2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00235	0.0229	CbGpPWpGaD
Epinastine—HTR7—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00234	0.0228	CbGpPWpGaD
Epinastine—HRH2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00219	0.0213	CbGpPWpGaD
Epinastine—HRH2—nervous system—Gilles de la Tourette syndrome	0.00216	0.051	CbGeAlD
Epinastine—HRH2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00212	0.0207	CbGpPWpGaD
Epinastine—HRH2—central nervous system—Gilles de la Tourette syndrome	0.00207	0.0491	CbGeAlD
Epinastine—HTR7—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00199	0.0194	CbGpPWpGaD
Epinastine—HRH2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00198	0.0193	CbGpPWpGaD
Epinastine—HTR7—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00193	0.0189	CbGpPWpGaD
Epinastine—HTR7—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0018	0.0176	CbGpPWpGaD
Epinastine—HTR7—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00168	0.0163	CbGpPWpGaD
Epinastine—HRH2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00165	0.0161	CbGpPWpGaD
Epinastine—HRH2—brain—Gilles de la Tourette syndrome	0.00165	0.039	CbGeAlD
Epinastine—HTR7—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00163	0.0159	CbGpPWpGaD
Epinastine—HTR7—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00151	0.0148	CbGpPWpGaD
Epinastine—HTR2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0015	0.0146	CbGpPWpGaD
Epinastine—HRH1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00149	0.0146	CbGpPWpGaD
Epinastine—ADRA1A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00146	0.0143	CbGpPWpGaD
Epinastine—HRH2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00138	0.0135	CbGpPWpGaD
Epinastine—ADRA2A—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.00136	0.0133	CbGpPWpGaD
Epinastine—HTR7—midbrain—Gilles de la Tourette syndrome	0.00133	0.0316	CbGeAlD
Epinastine—HTR2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00128	0.0124	CbGpPWpGaD
Epinastine—HRH1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00127	0.0124	CbGpPWpGaD
Epinastine—HTR7—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00126	0.0123	CbGpPWpGaD
Epinastine—ADRA1A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00125	0.0122	CbGpPWpGaD
Epinastine—HTR2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00124	0.0121	CbGpPWpGaD
Epinastine—HRH1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00124	0.012	CbGpPWpGaD
Epinastine—ADRA1A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00121	0.0118	CbGpPWpGaD
Epinastine—ADRA2A—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.00116	0.0113	CbGpPWpGaD
Epinastine—HTR2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00115	0.0112	CbGpPWpGaD
Epinastine—HRH1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00115	0.0112	CbGpPWpGaD
Epinastine—ADRA1A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00113	0.011	CbGpPWpGaD
Epinastine—ADRA2A—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.00113	0.011	CbGpPWpGaD
Epinastine—Mirtazapine—DRD4—Gilles de la Tourette syndrome	0.00111	0.0971	CrCbGaD
Epinastine—HTR7—nervous system—Gilles de la Tourette syndrome	0.0011	0.0259	CbGeAlD
Epinastine—HTR2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00107	0.0105	CbGpPWpGaD
Epinastine—HRH1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00107	0.0104	CbGpPWpGaD
Epinastine—HTR7—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00106	0.0103	CbGpPWpGaD
Epinastine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.00106	0.025	CbGeAlD
Epinastine—HTR7—central nervous system—Gilles de la Tourette syndrome	0.00105	0.025	CbGeAlD
Epinastine—ADRA1A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.00105	0.0102	CbGpPWpGaD
Epinastine—ADRA2A—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.00105	0.0102	CbGpPWpGaD
Epinastine—HTR2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00104	0.0101	CbGpPWpGaD
Epinastine—HRH1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00104	0.0101	CbGpPWpGaD
Epinastine—ADRA1A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.00102	0.00994	CbGpPWpGaD
Epinastine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.00102	0.0241	CbGeAlD
Epinastine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000977	0.0231	CbGeAlD
Epinastine—ADRA2A—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.000976	0.00951	CbGpPWpGaD
Epinastine—HTR2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00097	0.00945	CbGpPWpGaD
Epinastine—HRH1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000968	0.00943	CbGpPWpGaD
Epinastine—Mirtazapine—DRD3—Gilles de la Tourette syndrome	0.000959	0.0837	CrCbGaD
Epinastine—ADRA1A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00095	0.00926	CbGpPWpGaD
Epinastine—ADRA2A—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.000947	0.00923	CbGpPWpGaD
Epinastine—Mirtazapine—SLC6A3—Gilles de la Tourette syndrome	0.000892	0.0779	CrCbGaD
Epinastine—HTR7—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000885	0.00863	CbGpPWpGaD
Epinastine—ADRA2A—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.000882	0.0086	CbGpPWpGaD
Epinastine—HTR7—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.000859	0.00838	CbGpPWpGaD
Epinastine—CYP2B6—nervous system—Gilles de la Tourette syndrome	0.000838	0.0198	CbGeAlD
Epinastine—HTR7—brain—Gilles de la Tourette syndrome	0.000837	0.0198	CbGeAlD
Epinastine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000831	0.0197	CbGeAlD
Epinastine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000818	0.0194	CbGeAlD
Epinastine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000808	0.0191	CbGeAlD
Epinastine—CYP2B6—central nervous system—Gilles de la Tourette syndrome	0.000806	0.0191	CbGeAlD
Epinastine—HRH1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000806	0.00786	CbGpPWpGaD
Epinastine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000804	0.019	CbGeAlD
Epinastine—ADRA1A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000791	0.00771	CbGpPWpGaD
Epinastine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000788	0.0187	CbGeAlD
Epinastine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000774	0.0183	CbGeAlD
Epinastine—ADRA2A—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.000735	0.00717	CbGpPWpGaD
Epinastine—Mianserin—DRD3—Gilles de la Tourette syndrome	0.000705	0.0615	CrCbGaD
Epinastine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000683	0.0162	CbGeAlD
Epinastine—HRH1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000678	0.00661	CbGpPWpGaD
Epinastine—ADRA1A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000665	0.00648	CbGpPWpGaD
Epinastine—Mirtazapine—DRD2—Gilles de la Tourette syndrome	0.000663	0.0579	CrCbGaD
Epinastine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000658	0.0156	CbGeAlD
Epinastine—Mianserin—SLC6A3—Gilles de la Tourette syndrome	0.000656	0.0572	CrCbGaD
Epinastine—CYP2B6—brain—Gilles de la Tourette syndrome	0.00064	0.0152	CbGeAlD
Epinastine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000633	0.015	CbGeAlD
Epinastine—HRH1—brain—Gilles de la Tourette syndrome	0.000625	0.0148	CbGeAlD
Epinastine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000622	0.0147	CbGeAlD
Epinastine—ADRA2A—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.000618	0.00602	CbGpPWpGaD
Epinastine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000614	0.0145	CbGeAlD
Epinastine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000609	0.0144	CbGeAlD
Epinastine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.000599	0.0142	CbGeAlD
Epinastine—HTR2A—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.000567	0.00552	CbGpPWpGaD
Epinastine—HTR7—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.000561	0.00547	CbGpPWpGaD
Epinastine—Trimipramine—SLC6A3—Gilles de la Tourette syndrome	0.000552	0.0482	CrCbGaD
Epinastine—HTR2A—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00055	0.00536	CbGpPWpGaD
Epinastine—ABCB1—midbrain—Gilles de la Tourette syndrome	0.000545	0.0129	CbGeAlD
Epinastine—HTR2A—brain—Gilles de la Tourette syndrome	0.000522	0.0124	CbGeAlD
Epinastine—Mirtazapine—HTR2A—Gilles de la Tourette syndrome	0.000513	0.0448	CrCbGaD
Epinastine—HRH2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000502	0.00489	CbGpPWpGaD
Epinastine—Mianserin—DRD2—Gilles de la Tourette syndrome	0.000488	0.0426	CrCbGaD
Epinastine—HRH2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000487	0.00475	CbGpPWpGaD
Epinastine—Desipramine—SLC6A3—Gilles de la Tourette syndrome	0.000482	0.0421	CrCbGaD
Epinastine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000476	0.0113	CbGeAlD
Epinastine—HTR7—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00047	0.00458	CbGpPWpGaD
Epinastine—HTR7—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.000456	0.00444	CbGpPWpGaD
Epinastine—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000454	0.00443	CbGpPWpGaD
Epinastine—ABCB1—nervous system—Gilles de la Tourette syndrome	0.000448	0.0106	CbGeAlD
Epinastine—Amitriptyline—DRD3—Gilles de la Tourette syndrome	0.000437	0.0381	CrCbGaD
Epinastine—Nortriptyline—DRD2—Gilles de la Tourette syndrome	0.000436	0.038	CrCbGaD
Epinastine—ABCB1—central nervous system—Gilles de la Tourette syndrome	0.000431	0.0102	CbGeAlD
Epinastine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00043	0.00419	CbGpPWpGaD
Epinastine—HTR7—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.000425	0.00414	CbGpPWpGaD
Epinastine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000418	0.00407	CbGpPWpGaD
Epinastine—Trimipramine—DRD2—Gilles de la Tourette syndrome	0.00041	0.0358	CrCbGaD
Epinastine—Imipramine—SLC6A3—Gilles de la Tourette syndrome	0.000409	0.0357	CrCbGaD
Epinastine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000389	0.00379	CbGpPWpGaD
Epinastine—HTR7—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000385	0.00375	CbGpPWpGaD
Epinastine—Mianserin—HTR2A—Gilles de la Tourette syndrome	0.000377	0.0329	CrCbGaD
Epinastine—HTR7—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000373	0.00364	CbGpPWpGaD
Epinastine—Desipramine—DRD2—Gilles de la Tourette syndrome	0.000359	0.0313	CrCbGaD
Epinastine—HTR7—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000348	0.00339	CbGpPWpGaD
Epinastine—ABCB1—brain—Gilles de la Tourette syndrome	0.000342	0.00811	CbGeAlD
Epinastine—Nortriptyline—HTR2A—Gilles de la Tourette syndrome	0.000337	0.0294	CrCbGaD
Epinastine—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000329	0.00321	CbGpPWpGaD
Epinastine—HRH2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000328	0.00319	CbGpPWpGaD
Epinastine—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00032	0.00312	CbGpPWpGaD
Epinastine—HRH2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000318	0.0031	CbGpPWpGaD
Epinastine—HRH2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000318	0.0031	CbGpPWpGaD
Epinastine—Trimipramine—HTR2A—Gilles de la Tourette syndrome	0.000317	0.0277	CrCbGaD
Epinastine—Imipramine—DRD2—Gilles de la Tourette syndrome	0.000304	0.0266	CrCbGaD
Epinastine—Amitriptyline—DRD2—Gilles de la Tourette syndrome	0.000302	0.0264	CrCbGaD
Epinastine—HTR7—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000298	0.0029	CbGpPWpGaD
Epinastine—HRH2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000296	0.00289	CbGpPWpGaD
Epinastine—Desipramine—HTR2A—Gilles de la Tourette syndrome	0.000277	0.0242	CrCbGaD
Epinastine—HRH2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000272	0.00266	CbGpPWpGaD
Epinastine—HTR7—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000251	0.00245	CbGpPWpGaD
Epinastine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000246	0.0024	CbGpPWpGaD
Epinastine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000246	0.0024	CbGpPWpGaD
Epinastine—HTR7—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000244	0.00237	CbGpPWpGaD
Epinastine—HTR7—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000244	0.00237	CbGpPWpGaD
Epinastine—ADRA2A—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.000241	0.00235	CbGpPWpGaD
Epinastine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000241	0.00235	CbGpPWpGaD
Epinastine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000239	0.00233	CbGpPWpGaD
Epinastine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000239	0.00233	CbGpPWpGaD
Epinastine—Imipramine—HTR2A—Gilles de la Tourette syndrome	0.000235	0.0205	CrCbGaD
Epinastine—ADRA2A—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.000234	0.00228	CbGpPWpGaD
Epinastine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000234	0.00228	CbGpPWpGaD
Epinastine—Amitriptyline—HTR2A—Gilles de la Tourette syndrome	0.000234	0.0204	CrCbGaD
Epinastine—HTR7—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000227	0.00221	CbGpPWpGaD
Epinastine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.000224	0.00218	CbGpPWpGaD
Epinastine—HTR2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000223	0.00217	CbGpPWpGaD
Epinastine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000222	0.00217	CbGpPWpGaD
Epinastine—ADRA2A—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.000218	0.00213	CbGpPWpGaD
Epinastine—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000218	0.00213	CbGpPWpGaD
Epinastine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.000217	0.00212	CbGpPWpGaD
Epinastine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000211	0.00206	CbGpPWpGaD
Epinastine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00021	0.00205	CbGpPWpGaD
Epinastine—HTR7—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000209	0.00203	CbGpPWpGaD
Epinastine—HRH2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000207	0.00202	CbGpPWpGaD
Epinastine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000207	0.00201	CbGpPWpGaD
Epinastine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000205	0.002	CbGpPWpGaD
Epinastine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000204	0.00199	CbGpPWpGaD
Epinastine—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.000203	0.00197	CbGpPWpGaD
Epinastine—HRH1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000201	0.00196	CbGpPWpGaD
Epinastine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000201	0.00195	CbGpPWpGaD
Epinastine—ADRA1A—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.000198	0.00193	CbGpPWpGaD
Epinastine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.000192	0.00187	CbGpPWpGaD
Epinastine—HTR2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000191	0.00186	CbGpPWpGaD
Epinastine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00019	0.00186	CbGpPWpGaD
Epinastine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000187	0.00182	CbGpPWpGaD
Epinastine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.000186	0.00182	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000185	0.0018	CbGpPWpGaD
Epinastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00018	0.00176	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00018	0.00175	CbGpPWpGaD
Epinastine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.000177	0.00172	CbGpPWpGaD
Epinastine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.000174	0.00169	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000168	0.00164	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000167	0.00163	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000163	0.00159	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000161	0.00157	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00016	0.00156	CbGpPWpGaD
Epinastine—HTR7—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000159	0.00155	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000157	0.00153	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000156	0.00152	CbGpPWpGaD
Epinastine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000156	0.00152	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000156	0.00152	CbGpPWpGaD
Epinastine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000153	0.00149	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000153	0.00149	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000152	0.00148	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.000146	0.00142	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000145	0.00142	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000145	0.00141	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000142	0.00139	CbGpPWpGaD
Epinastine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.000142	0.00138	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.000142	0.00138	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000142	0.00138	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	0.00014	0.00137	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000138	0.00134	CbGpPWpGaD
Epinastine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000133	0.0013	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.000132	0.00129	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—HDC—Gilles de la Tourette syndrome	0.000131	0.00128	CbGpPWpGaD
Epinastine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000131	0.00128	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000129	0.00126	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000128	0.00125	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000125	0.00122	CbGpPWpGaD
Epinastine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.000122	0.00119	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000117	0.00114	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000116	0.00114	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000106	0.00104	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.000102	0.00099	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.96e-05	0.000971	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	9.93e-05	0.000968	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—HDC—Gilles de la Tourette syndrome	9.69e-05	0.000945	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	9.64e-05	0.00094	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	9.26e-05	0.000902	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	9.13e-05	0.00089	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.08e-05	0.000885	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	9.06e-05	0.000883	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	8.98e-05	0.000876	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	8.98e-05	0.000875	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.89e-05	0.000867	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.81e-05	0.000859	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.79e-05	0.000857	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.63e-05	0.000841	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	8.26e-05	0.000805	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.24e-05	0.000804	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.23e-05	0.000802	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.21e-05	0.0008	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.19e-05	0.000799	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	8.16e-05	0.000795	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	8.07e-05	0.000787	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	8.04e-05	0.000784	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	8.02e-05	0.000782	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	8e-05	0.00078	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.99e-05	0.000778	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.84e-05	0.000764	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	7.61e-05	0.000742	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	7.5e-05	0.000731	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	7.47e-05	0.000728	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.46e-05	0.000727	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.44e-05	0.000725	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	7.38e-05	0.00072	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	7.3e-05	0.000712	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	7.28e-05	0.00071	CbGpPWpGaD
Epinastine—ABCB1—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	7.2e-05	0.000702	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	6.88e-05	0.000671	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	6.78e-05	0.000661	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	6.29e-05	0.000613	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	5.97e-05	0.000582	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.74e-05	0.000559	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.63e-05	0.000549	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.23e-05	0.00051	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.21e-05	0.000508	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.11e-05	0.000498	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.87e-05	0.000475	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.86e-05	0.000474	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	4.82e-05	0.00047	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.77e-05	0.000465	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	4.75e-05	0.000463	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.73e-05	0.000461	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.72e-05	0.00046	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.63e-05	0.000451	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.43e-05	0.000432	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.4e-05	0.000429	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.39e-05	0.000428	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.31e-05	0.00042	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.3e-05	0.000419	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.01e-05	0.000391	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.08e-05	0.0003	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.02e-05	0.000294	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	2.81e-05	0.000274	CbGpPWpGaD
